Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Congenital neuronal ceroid lipofuscinosis (CNCL) is a severe form of neuronal ceroid lipofuscinosis (NCL; see this term) with onset at birth characterized by primary microcephaly, neonatal epilepsy, and death in early infancy.
2 clinical trials registered, 2 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
3 publications have been identified in PubMed for congenital neuronal ceroid lipofuscinosis. Research spans Review / Meta-Analysis (33%), Case Report / Case Series (33%), and Basic Science / Preclinical (33%).
Zhao JQ (2025). [PMID: 39284877](https://pubmed.ncbi.nlm.nih.gov/39284877/). *Acta Pharmacol Sin*. [Basic Science / Preclinical]
Çiçek S (2024). [PMID: 39656415](https://pubmed.ncbi.nlm.nih.gov/39656415/). *Cerebellum*. [Review / Meta-Analysis]
Baltar F (2024). [PMID: 38751748](https://pubmed.ncbi.nlm.nih.gov/38751748/). *Front Pediatr*. [Case Report / Case Series]
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 1:03 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center